Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Innovita Biological Technology
Beijing, Beijing, Chinainnovita-pharma.com ↗
- Ownership
- Private
- Employees
- ~439
- Development stage
- Commercial
01
Overview
Innovita Biological Technology develops, manufactures, and markets point-of-care testing (POCT) in vitro diagnostic products using technologies such as colloidal gold immunoassay, real-time PCR, chemiluminescence immunoassay, ELISA, and biochips. The company operates large-scale GMP-compliant manufacturing facilities and has an established global presence with its rapid tests used for infectious disease detection and general health screening.
- Therapeutic areas
- OtherInfectious Diseases
- Modalities
- Diagnostic deviceIn-vitro diagnostic test
- Industry
- Molecular Diagnostics
Beyond the preview
Go deeper on Innovita Biological Technology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Innovita Biological Technology.